DeepMed Research

UNIVERSITY OF CINCINNATI

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1819-01-01

Employees: 5.9K

Market Cap: -

Website: https://www.uc.edu/

Clinical Trials

Asenapine for Bipolar Depression

Phase 2

Terminated

Conditions: Bipolar Depression

Interventions: Drug: Placebo
Drug: Asenapine

First Posted Date: 2013-03-08

Last Posted Date: 2017-07-24

Lead Sponsor: University of Cincinnati

Target Recruit Count: 51

Registration Number: NCT01807741

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline

Not Applicable

Completed

Conditions: Age-related Memory Disorders
Mood Disorders

Interventions: Dietary Supplement: Omega-3 fatty acid
Other: Placebo oil
Dietary Supplement: Blueberry powder
Other: Placebo powder

First Posted Date: 2012-12-10

Last Posted Date: 2016-05-27

Lead Sponsor: University of Cincinnati

Target Recruit Count: 94

Registration Number: NCT01746303

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study)

Phase 4

Completed

Conditions: Epilepsy

Interventions: Drug: Lamotrigine Generic "A" Lamotrigine Generic "B" Lamotrigine "Brand"
Drug: lamotrigine

First Posted Date: 2012-11-27

Last Posted Date: 2017-07-19

Lead Sponsor: University of Cincinnati

Target Recruit Count: 54

Registration Number: NCT01733394

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Drake University, Des Moines, Iowa, United States

and more 5 locations

Belatacept Early Steroid Withdrawal Trial

Phase 4

Completed

Conditions: Renal Transplantation

Interventions: Drug: Alemtuzumab
Drug: rabbit antithymocyte globulin
Drug: Tacrolimus
Drug: Belatacept
Drug: Mycophenolate mofetil
Drug: early cessation of steroids

First Posted Date: 2012-11-20

Last Posted Date: 2021-07-28

Lead Sponsor: University of Cincinnati

Target Recruit Count: 316

Registration Number: NCT01729494

Locations: 🇺🇸
University of Wisconsin-Madison, Madison, Wisconsin, United States
🇺🇸
Tampa General Hospital, Tampa, Florida, United States
🇺🇸
The Christ Hospital, Cincinnati, Ohio, United States

and more 5 locations

Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics

Active, not recruiting

Conditions: Coronary Artery Disease

Interventions: Procedure: Cardiac PET, Coronary catheterization

First Posted Date: 2012-11-01

Last Posted Date: 2024-02-28

Lead Sponsor: University of Cincinnati

Target Recruit Count: 68

Registration Number: NCT01719016

Locations: 🇺🇸
Cincinnati Veteran Affairs Medical Center, Cincinnati, Ohio, United States

Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design

Phase 4

Completed

Conditions: Epilepsy

Interventions: Drug: Lamotrigine Generic "A"
Drug: Lamotrigine generic "B"

First Posted Date: 2012-10-25

Last Posted Date: 2015-10-01

Lead Sponsor: University of Cincinnati

Target Recruit Count: 35

Registration Number: NCT01713777

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Drake University, Des Moines, Iowa, United States
🇺🇸
Michel J. Berg, MD, Rochester, New York, United States

and more 5 locations

Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage

Completed

Conditions: Hemorrhage

First Posted Date: 2012-10-18

Last Posted Date: 2016-08-09

Lead Sponsor: University of Cincinnati

Target Recruit Count: 88

Registration Number: NCT01709786

Locations: 🇺🇸
University Hospital, Cincinnati, Ohio, United States

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Procedure: 3-Tesla magnetic resonance imaging (3T MRI)
Procedure: diffusion-weighted magnetic resonance imaging
Procedure: dynamic contrast-enhanced magnetic resonance imaging
Procedure: magnetic resonance spectroscopic imaging

First Posted Date: 2012-07-30

Last Posted Date: 2025-04-11

Lead Sponsor: University of Cincinnati

Target Recruit Count: 280

Registration Number: NCT01653093

Locations: 🇺🇸
The Ohio State University Medical Center, Stress, Columbus, Ohio, United States

MRI in Diagnosing Solid Tumors of the Eye and Orbit

Not Applicable

Active, not recruiting

Conditions: Eye Cancer

Interventions: Procedure: dynamic contrast-enhanced MRI

First Posted Date: 2012-07-30

Last Posted Date: 2025-04-11

Lead Sponsor: University of Cincinnati

Target Recruit Count: 80

Registration Number: NCT01653080

Locations: 🇺🇸
Ohio State University Medical Center, Columbus, Ohio, United States

Study of Buspirone for Relapse-Prevention in Adults With Cocaine Dependence

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Placebo
Drug: Buspirone

First Posted Date: 2012-07-16

Last Posted Date: 2015-01-07

Lead Sponsor: University of Cincinnati

Target Recruit Count: 62

Registration Number: NCT01641159

Locations: 🇺🇸
Maryhaven Inc, Columbus, Ohio, United States
🇺🇸
Penn Presbyterian, Philadelphia, Pennsylvania, United States
🇺🇸
Addiction Medicine Services, Pittsburgh, Pennsylvania, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy